117 related articles for article (PubMed ID: 16315895)
21. [Repeated intraperitoneal chemotherapy for peritoneal dissemination from gastric carcinoma].
Arai K; Iwasaki Y; Takahashi T
Gan To Kagaku Ryoho; 2001 Sep; 28(9):1257-61. PubMed ID: 11579636
[TBL] [Abstract][Full Text] [Related]
22. Advanced gastric carcinoma with signet ring cell histology.
Li C; Kim S; Lai JF; Hyung WJ; Choi WH; Choi SH; Noh SH
Oncology; 2007; 72(1-2):64-8. PubMed ID: 18004078
[TBL] [Abstract][Full Text] [Related]
23. Molecular characterization and significance for prognosis of free gastric cancer cells in the peritoneal cavity.
Li C; Ma Y; Xue Y; Zhang H; Wei Y
Hepatogastroenterology; 2009; 56(91-92):891-8. PubMed ID: 19621724
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of peritoneal lavage cytology at three cavities in patients with gastric cancer.
Kano Y; Kosugi S; Ishikawa T; Otani T; Muneoka Y; Sato Y; Hanyu T; Hirashima K; Bamba T; Wakai T
Surgery; 2015 Dec; 158(6):1581-9. PubMed ID: 25958064
[TBL] [Abstract][Full Text] [Related]
25. Multivariate prognostic study on large gastric cancer.
Shiraishi N; Sato K; Yasuda K; Inomata M; Kitano S
J Surg Oncol; 2007 Jul; 96(1):14-8. PubMed ID: 17582596
[TBL] [Abstract][Full Text] [Related]
26. The detection of microscopically disseminated cancer cells in the abdominal cavity by intraoperative lavage cytology combined with an immunocytochemical method in gastric cancer.
Imada T; Rino Y; Cyo H; Oshima T; Hatori S; Wakebe S; Kabara K; Shiozawa M; Takahashi M; Takanashi Y
Anticancer Res; 1999; 19(6B):4965-8. PubMed ID: 10697497
[TBL] [Abstract][Full Text] [Related]
27. Macroscopic Borrmann type as a simple prognostic indicator in patients with advanced gastric cancer.
Li C; Oh SJ; Kim S; Hyung WJ; Yan M; Zhu ZG; Noh SH
Oncology; 2009; 77(3-4):197-204. PubMed ID: 19729977
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer.
Saito H; Fukumoto Y; Osaki T; Yamada Y; Fukuda K; Tatebe S; Tsujitani S; Ikeguchi M
J Surg Oncol; 2008 Feb; 97(2):132-5. PubMed ID: 17979134
[TBL] [Abstract][Full Text] [Related]
29. Macroscopic tumor size as a simple prognostic indicator in patients with gastric cancer.
Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Oro S; Tatebe S; Tsujitani S; Ikeguchi M
Am J Surg; 2006 Sep; 192(3):296-300. PubMed ID: 16920421
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
31. High CD40 expression in gastric cancer associated with expanding type histology and liver metastasis.
Lo SS; Wu CW; Chi CW; Li AF; Chen JH; Lui WY
Hepatogastroenterology; 2005; 52(66):1902-4. PubMed ID: 16334803
[TBL] [Abstract][Full Text] [Related]
32. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
[TBL] [Abstract][Full Text] [Related]
33. [Treatment strategy for the type IV gastric cancer--from the standpoint of the surgery].
Nashimoto A; Yabusaki H; Nakagawa S
Gan To Kagaku Ryoho; 2007 Jul; 34(7):983-7. PubMed ID: 17637531
[TBL] [Abstract][Full Text] [Related]
34. Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas.
Li X; Zheng H; Hara T; Takahashi H; Masuda S; Wang Z; Yang X; Guan Y; Takano Y
Int J Oncol; 2008 Jul; 33(1):69-79. PubMed ID: 18575752
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathologic characteristics and surgical outcomes of mucinous gastric carcinoma.
Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H
Ann Surg Oncol; 2006 Jun; 13(6):836-42. PubMed ID: 16604474
[TBL] [Abstract][Full Text] [Related]
37. Strong association of lymph node metastasis with intraperitoneal free cancer cell (IFCC) in advanced gastric cancer.
Yamashita K; Sakuramoto S; Kikuchi S; Katada N; Kobayashi N; Watanabe M
Hepatogastroenterology; 2008; 55(86-87):1873-7. PubMed ID: 19102412
[TBL] [Abstract][Full Text] [Related]
38. Clinical implication of CXCL12 expression in gastric cancer.
Ishigami S; Natsugoe S; Okumura H; Matsumoto M; Nakajo A; Uenosono Y; Arigami T; Uchikado Y; Setoyama T; Arima H; Hokita S; Aikou T
Ann Surg Oncol; 2007 Nov; 14(11):3154-8. PubMed ID: 17653799
[TBL] [Abstract][Full Text] [Related]
39. Metastatic potential in T1 and T2 colorectal cancer.
Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
[TBL] [Abstract][Full Text] [Related]
40. p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate.
Galizia G; Ferraraccio F; Lieto E; Orditura M; Castellano P; Imperatore V; La Manna G; Pinto M; Ciardiello F; La Mura A; De Vita F
J Surg Oncol; 2006 Mar; 93(3):241-52. PubMed ID: 16482605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
